Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene.

Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KC, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie WR, Wigler MH, Powers S.

Cancer Cell. 2003 Mar;3(3):297-302.

2.
3.

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.

Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C.

Oncogene. 2005 Aug 4;24(33):5235-45.

PMID:
15897872
4.

The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG.

Cancer Res. 2002 Sep 15;62(18):5273-9.

5.

Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.

Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP.

Cancer Res. 2004 Jan 1;64(1):40-7.

6.

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.

Karlsson E, Waltersson MA, Bostner J, Pérez-Tenorio G, Olsson B, Hallbeck AL, Stål O.

Genes Chromosomes Cancer. 2011 Oct;50(10):775-87. doi: 10.1002/gcc.20900. Epub 2011 Jul 11.

PMID:
21748818
7.

Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.

Tripathy D, Benz CC.

Cancer Treat Res. 1992;63:15-60. Review.

PMID:
1363356
8.

Comprehensive profiling of 8p11-12 amplification in breast cancer.

Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rougé C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyriès S, Adélaïde J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M.

Mol Cancer Res. 2005 Dec;3(12):655-67.

9.

The 17q23 amplicon and breast cancer.

Sinclair CS, Rowley M, Naderi A, Couch FJ.

Breast Cancer Res Treat. 2003 Apr;78(3):313-22. Review.

PMID:
12755490
10.

Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.

Bärlund M, Monni O, Weaver JD, Kauraniemi P, Sauter G, Heiskanen M, Kallioniemi OP, Kallioniemi A.

Genes Chromosomes Cancer. 2002 Dec;35(4):311-7.

PMID:
12378525
11.

Systems consequences of amplicon formation in human breast cancer.

Inaki K, Menghi F, Woo XY, Wagner JP, Jacques PÉ, Lee YF, Shreckengast PT, Soon WW, Malhotra A, Teo AS, Hillmer AM, Khng AJ, Ruan X, Ong SH, Bertrand D, Nagarajan N, Karuturi RK, Miranda AH, Liu ET.

Genome Res. 2014 Oct;24(10):1559-71. doi: 10.1101/gr.164871.113. Epub 2014 Sep 3.

12.

New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.

Kauraniemi P, Bärlund M, Monni O, Kallioniemi A.

Cancer Res. 2001 Nov 15;61(22):8235-40.

13.

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.

Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW, Powers S.

Nat Genet. 2002 Jun;31(2):133-4. Epub 2002 May 20.

PMID:
12021784
14.

Genomic analysis of the 8p11-12 amplicon in familial breast cancer.

Melchor L, Garcia MJ, Honrado E, Pole JC, Alvarez S, Edwards PA, Caldas C, Brenton JD, Benítez J.

Int J Cancer. 2007 Feb 1;120(3):714-7.

15.

Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe.

Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P.

Hum Genet. 1993 Feb;90(6):584-9.

PMID:
8383093
16.

PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.

Mahmood SF, Gruel N, Nicolle R, Chapeaublanc E, Delattre O, Radvanyi F, Bernard-Pierrot I.

Am J Pathol. 2013 Nov;183(5):1634-44. doi: 10.1016/j.ajpath.2013.07.028. Epub 2013 Sep 17.

PMID:
24051013
18.

Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.

Bièche I, Tomasetto C, Régnier CH, Moog-Lutz C, Rio MC, Lidereau R.

Cancer Res. 1996 Sep 1;56(17):3886-90.

19.

Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.

Yang ZQ, Albertson D, Ethier SP.

Cancer Genet Cytogenet. 2004 Nov;155(1):57-62.

PMID:
15527903
20.

Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.

Rodriguez V, Chen Y, Elkahloun A, Dutra A, Pak E, Chandrasekharappa S.

Genes Chromosomes Cancer. 2007 Jul;46(7):694-707.

PMID:
17440925

Supplemental Content

Support Center